Sagent Pharm Inc (SGNT) 21.76 $SGNT Nichi-Iko

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sagent Pharm Inc (SGNT) 21.76 $SGNT

Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Sagent Pharmaceuticals, Inc.
BusinessWire - Mon Aug 29, 6:58AM CDT
Nichi-Iko Pharmaceutical Co., Ltd. (TSE:4541) ("Nichi-Iko" or "Parent" today announced the results of its tender offer to purchase all of the outstanding shares of common stock of Sagent Pharmaceuticals, Inc. ("Sagent" (NASDAQ:SGNT) at $21.75 per share, net to the holder in cash, without interest, less any applicable withholding taxes. The tender offer was effected by Nichi-Iko's wholly-owned subsidiary, Shepard Vision, Inc. (the "Purchaser".
SGNT: 21.76 (+0.03)

Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600
PR Newswire - Mon Aug 22, 4:51PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
SPGI: 123.94 (+0.40), TLMR: 23.26 (-0.44), SVU: 5.51 (+0.03), SCVL: 26.18 (-3.48), FCFS: 50.32 (-1.40), SGNT: 21.76 (+0.03), EGRX: 59.02 (-0.73), CHFC: 45.01 (-1.22), CSH: 42.20 (-1.33)

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron oxide particulate matter
GlobeNewswire - Wed Aug 17, 4:44PM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10 g (NDC 25021-163-99) Lot OXT512 (Exp. Date March 2017) manufactured by Astral SteriTech Private Limited and distributed by Sagent. Sagent has initiated this voluntary recall to the user level due to the receipt of a product complaint for a single vial containing small, dark particulate matter found within the solution after reconstitution. The particulate matter has been identified as iron oxide.
SGNT: 21.76 (+0.03)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sagent Pharmaceuticals, Inc. (SGNT)
GlobeNewswire - Wed Aug 10, 6:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Sagent Pharmaceuticals, Inc. ("Sagent" or the "Company" (Nasdaq:SGNT) in the United States District Court for the Northern District of Illinois on behalf of current stock holders of Sagent, seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act".
SGNT: 21.76 (+0.03)

Nichi-Iko Pharmaceutical Co., Ltd. Announces Expiration of HSR Waiting Period for Proposed Acquisition of Sagent Pharmaceuticals, Inc.
BusinessWire - Tue Aug 09, 8:25AM CDT
Nichi-Iko Pharmaceutical Co., Ltd. (TSE: 4541) ("Nichi-Iko" or "Parent" and Shepard Vision, Inc. ("Purchaser" announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR", with respect to its proposed acquisition of Sagent Pharmaceuticals, Inc. ("Sagent"; Nasdaq: SGNT) expired effective August 8, 2016, at 11:59 p.m. (Eastern Daylight Time).
SGNT: 21.76 (+0.03)

What Awaits MNK & Other Drug Stocks this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:00AM CDT
Let's see what's in store for some medical companies that are expected to declare quarterly numbers on Aug 2.
MNK: 75.59 (+1.05), BIIB: 306.03 (+0.40), ABT: 42.30 (+0.28), JNJ: 119.08 (-0.26), GILD: 77.42 (-0.96), MRK: 62.90 (+0.11), PFE: 34.68 (-0.12), SGNT: 21.76 (+0.03), ABBV: 64.03 (-0.07), PRTA: 52.21 (+2.23), NVS: 78.27 (-0.50)

Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75 Net Per Share to Acquire All Outstanding Shares of Sagent Pharmaceuticals, Inc.
BusinessWire - Mon Aug 01, 8:55AM CDT
Shepard Vision, Inc., a Delaware corporation (the "Purchaser" and a wholly-owned subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. (the "Parent", a joint stock corporation organized under the laws of Japan, today announced that it has commenced its previously announced tender offer to acquire all of the outstanding shares of common stock of Sagent Pharmaceuticals, Inc. ("Sagent", a Delaware corporation (NASDAQ: SGNT), at a price of $21.75 per Share (the "Offer Price", net to the holder in cash, without interest, less any applicable withholding taxes (the "Offer".
SGNT: 21.76 (+0.03)

Sapiens Names Andre M. Boisvert Chairman of Sapiens DECISION Board of Directors
PR Newswire - Thu Jul 28, 8:12AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the financial services sector, announced today that veteran software industry executive, private investor and technology consultant Andre M. Boisvert was nominated to serve as the chairman of the board of directors of Sapiens DECISION.
SPNS: 13.55 (+0.10), ISDR: 7.25 (-0.07), SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd.
GlobeNewswire - Thu Jun 16, 7:00AM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leading provider of affordable pharmaceuticals to the hospital market, today announced that it has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (Teva) and Actavis LLC to acquire a portfolio of five Abbreviated New Drug Applications (ANDAs) in the U.S. for $40 million. The acquired portfolio includes products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business.
AGN: 237.76 (+3.22), SGNT: 21.76 (+0.03), TEVA: 50.90 (+0.51)

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Dark Particulate Matter
GlobeNewswire - Mon Jun 13, 4:52PM CDT
Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10g (NDC 25021-163-69) Lot OXT515 (Exp. Date July 2017) manufactured by Astral SteriTech Private Limited and distributed by Sagent. Sagent has initiated this voluntary recall of Oxacillin for Injection, USP, 10g to the user level due to the receipt of two product complaints for small, dark particulate matter found in solution after reconstitution. The presence of particulate matter during administration has the potential to cause adverse health consequences in general patient populations.
SGNT: 21.76 (+0.03)

Sagent reports 1Q loss
Automated Insights - Tue May 03, 6:52AM CDT
SCHAUMBURG, Ill. (AP) _ Sagent Pharmaceuticals Inc. (SGNT) on Tuesday reported a loss of $5 million in its first quarter.
SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 03, 6:30AM CDT
Company Affirms 2016 Full Year Guidance
SGNT: 21.76 (+0.03)

Athenex Announces Jeffrey Yordon to Lead Newly Formed Specialty Products Division
PR Newswire - Tue Apr 26, 7:00AM CDT
Athenex, Inc. announced today that Jeffrey Yordon has joined the Company as President of the newly formed subsidiary, Athenex Specialty Products. In this capacity, Mr. Yordon will be responsible for all aspects of the business unit including strategy, new products, manufacturing, distribution, sales and marketing.
SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2016 Financial Results
GlobeNewswire - Mon Apr 25, 8:07AM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, today announced that it will release financial results for the 2016 first quarter pre-market on Tuesday, May 3, 2016 and will host a teleconference and webcast at 9 a.m. ET to review the results.
SGNT: 21.76 (+0.03)

Stock Picking Strategy to Win Every Earnings Season
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 5:27PM CDT
We are running a great screen which will help you get into winning stocks ahead of every earnings season.
CPN: 12.13 (-0.35), INGN: 57.95 (-0.07), SGNT: 21.76 (+0.03), MTN: 160.50 (+2.07), PFSW: 9.81 (+0.16)

Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
GlobeNewswire - Wed Mar 23, 3:05PM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, announced the hiring of Sean Brynjelsen as Executive Vice President, Business Development. In this newly created role, Mr. Brynjelsen will develop and execute a strategy to drive long-term growth through the acceleration of product licensing, acquisition of products and portfolios as well as the execution of other M&A activity. Mr. Brynjelsen will report directly to Allan Oberman, Sagent's Chief Executive Officer.
SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals Sets Date and Time for Release of Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Wed Feb 03, 3:00PM CST
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced that it will release financial results for the 2015 fourth quarter and full year pre-market on Tuesday, February 16, 2016 and will host a teleconference and webcast at 9 a.m. ET to review the results.
SGNT: 21.76 (+0.03)

Why Sagent Pharmaceuticals Inc. Jumped Today
Brian Orelli, The Motley Fool - Motley Fool - Wed Jan 13, 2:53PM CST
What: Sagent Pharmaceuticals surged this morning and was up as much as 19% today after Reuters reported that the company has hired an investment bank to solicit bids to buy the generic-drug maker. So what: Reuters appears to have multiple...
PFE: 34.68 (-0.12), SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals Receives Innovative Technology Designation From Novation for GLYDO(R) (Lidocaine HCl Jelly USP, 2%)
GlobeNewswire - Tue Jan 12, 7:00AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) announced its GLYDO(R) (lidocaine HCl jelly USP, 2%) has received Innovative Technology designation from Novation, the leading healthcare services company that serves the more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association, and Provista. The designation was based on reviews of GLYDO by hospital experts who attended Novation's Innovative Technology Expo in November. The annual event provides medical technology suppliers the opportunity to demonstrate their product and gain direct feedback from onsite clinical experts and health care providers on the impact their products may have on improving clinical care, safety, or benefits to organization's care and business models.
SGNT: 21.76 (+0.03)

Sagent Pharmaceuticals to Present at 34th Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri Jan 08, 11:55AM CST
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will present at the 34 Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 13, 2016 at 2:00 p.m. PT (4:00 p.m. CT/5:00 p.m. ET). The presentation is being webcast and can be accessed on the "Events and Presentations" page of the "Investor Relations" section of the Company's website, www.sagentpharma.com. In order to register and download any necessary software, please log on 10 minutes prior to the start of the webcast.
JPM: 67.21 (-0.29), SGNT: 21.76 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 70

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 548

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 306

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 52

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 458

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 124

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

WIC Forum Set to Transform Cultural Heritage through Digitalization

Updated Category News Views 194

WIC Forum Set to Transform Cultural Heritage through Digitalization The World Internet Conference (WIC) recently held a significant press conference to announce the upcoming Cultural Heritage Digitalization Forum. This important event aims to explore the relationship between technology and cultural heritage preservation. Event Overview The WIC's briefing included key...

Continue Reading
Nordea Bank Rectifies Errors in Exchange Traded Products

Updated Category News Views 194

Correction of Errors in Exchange Traded Products Nordea Bank Abp, acting as the issuer, has identified and decided to amend certain final terms related to instruments listed in their documentation. This corrective action is taken based on identified manifest errors that needed rectification. The bank is entitled to make such modifications under subsection (i) of Condition...

Continue Reading
NEXE Innovations 2024 Review: A New Era of Sustainability Ahead

Updated Category News Views 324

Strategic Developments at NEXE Innovations NEXE Innovations Inc. (TSXV: NEXE) is making headlines with its impressive strides toward sustainable growth. This innovative company is dedicated to developing compostable materials to meet the rising demand for eco-friendly solutions. Their focus is on high-performance products that serve various markets, creating robust...

Continue Reading
Analyzing Affiliated Managers Group's Price-to-Earnings Ratio

Updated Category News Views 144

Understanding Affiliated Managers Group's Stock Performance In today's market, Affiliated Managers Group Inc. (NYSE: AMG) is trading at $281.79, reflecting a slight increase of 0.97%. Over the last month, the stock has appreciated by 5.89%, showcasing an impressive 50.30% rise over the past year. Such robust performance invites optimism among long-term investors, although...

Continue Reading
Revolutionizing Medical Device Development Through Live Prototyping

Updated Category News Views 182

Accelerating Medical Device Innovation In the fast-evolving world of healthcare technology, the demand for speed and efficiency has never been more critical. Elevaris Medical Devices, a prominent Contract Development and Manufacturing Organization (CDMO), is at the forefront of this transformation. They specialize in working with multi-national healthcare firms, global...

Continue Reading